News and Stories
-
Q&A: Meet ‘Mathemba Radebe, PIH Lesotho’s New Executive Director
Radebe, a PIHer since 2017, was born and raised in Lesotho.
-
A Young Mother’s Recovery from Paralysis in Sierra Leone
The Quality Essential Health Services and System Support Project (QEHSSSP) is transforming maternal and child health care for millions in Sierra Leone.
-
arcTB: A Patient-Focused Tuberculosis Treatment Initiative
Partners In Health (PIH) and Unitaid launched a groundbreaking project to improve care for people suffering from drug-resistant tuberculosis in seven high-burden countries.
-
"We Could Not Have Afforded the Care I Received": How PIH’s Right to Health Care Program Saves Lives in Rwanda
After months in the hospital without a diagnosis and depleted savings, Samuel Musabimana thought he was going to die. Instead, he received free health care from PIH, leading to an accurate diagnosis...
-
How PIH Staff Helped a Stranger Discover He Had TB
As PIHers in Malawi mobilized during Global Health Justice Week, one staff member noticed a man near the Zalewa Health Centre—and encouraged him to see a doctor. Now, he is in recovery from...
-
In Sierra Leone, Maternal Care is Being Reimagined to Prioritize Dignity
The Maternal Center of Excellence sets a new bar for maternal and neonatal care in Sierra Leone.
-
A Bold Vision for Global Health: The Paul Farmer Memorial Resolution
The Paul Farmer Memorial Resolution is a 21st-century global health strategy based on the life’s work of PIH’s Co-founder, the late Dr. Paul Farmer.
-
Foreign Aid Cuts Halt Migrant and Refugee Health Project in Peru
More than 7,000 Venezuelan migrants in Peru were set to benefit from comprehensive medical care, but recent actions by the U.S. government unraveled everything.
-
Didi Bertrand Farmer: In Paul Farmer’s Beautiful Garden of Global Health Equity
In the New England Journal of Medicine, Didi Bertrand Farmer reflects on PIH Co-founder Dr. Paul Farmer’s sudden passing over three years ago.
-
Elvis and Drug-Resistant Tuberculosis: The Clinical Study That Saved His Life
In Peru, endTB-Q's global clinical trial demonstrated that pre-XDR tuberculosis—one of the most resistant forms—can be treated in up to six months, without injections and with accompaniment.